Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 11, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cidara Therapeutics, Inc.
| 8K |
$13.21 | $105,680.00 | +48.25% | 24.58K |
Jun 7
| |||||||
Ideaya Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 31
| |||||||
Cidara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 15
| |||||||
Cidara Therapeutics, Inc.
| -56.69K |
$0.69 | -$39,117.48 | -4.68% | 1.15M |
Mar 11
| |||||||
Paratek Pharmaceuticals, Inc.
| -68.63K |
—
|
—
| -100.00% |
0
|
Sep 21
| |||||||
Cidara Therapeutics, Inc.
| 50K |
$0.96 | $47,885.00 | +17.76% | 331.6K |
Aug 8
| |||||||
Ideaya Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 7
| |||||||
Cidara Therapeutics, Inc.
| 271.75K |
—
|
—
| +29.20% | 1.2M |
Mar 27
| |||||||
Cidara Therapeutics, Inc.
| 50K |
$1.04 | $51,855.00 | +21.59% | 281.6K |
Mar 27
| |||||||
Paratek Pharmaceuticals, Inc.
| -7.00K |
$1.90 | -$13,300.00 | -9.26% | 68.63K |
Feb 21
|
Scheduled
| ||||||
Paratek Pharmaceuticals, Inc.
| 20K |
—
|
—
| +35.96% | 75.63K |
Feb 8
| |||||||
Ideaya Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Cidara Therapeutics, Inc.
| 432.76K |
$0.83 | -$117,017.55 | +88.34% | 922.63K |
Mar 31
| |||||||
Paratek Pharmaceuticals, Inc.
| 20K |
—
|
—
| +56.14% | 55.63K |
Feb 16
| |||||||
Cidara Therapeutics, Inc.
| 20K |
—
|
—
| +4.26% | 489.88K |
Dec 29
| |||||||
Cidara Therapeutics, Inc.
| 50K |
$1.59 | $79,530.00 | +12.02% | 465.88K |
Nov 12
| |||||||
Cidara Therapeutics, Inc.
| 50K |
$1.74 | $86,755.00 | +13.67% | 415.88K |
Aug 18 - Aug 19
| |||||||
Ideaya Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Cidara Therapeutics, Inc.
| 10K |
—
|
—
| +2.84% | 361.88K |
Mar 31
| |||||||
Cidara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 17
| |||||||
Paratek Pharmaceuticals, Inc.
| 9K |
—
|
—
| +33.80% | 35.63K |
Feb 18
| |||||||
Cidara Therapeutics, Inc.
| 50K |
$2.00 | $100,015.00 | +16.79% | 347.88K |
Nov 10
| |||||||
Ideaya Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 16
| |||||||
Cidara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 19
| |||||||
Paratek Pharmaceuticals, Inc.
| 9K |
—
|
—
| +51.06% | 26.63K |
Feb 19
| |||||||
Cidara Therapeutics, Inc.
| 39.84K |
$2.51 | $100,000.91 | +7.78% | 551.78K |
Jan 29
| |||||||
Ideaya Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 24
| |||||||
Cidara Therapeutics, Inc.
| 52.5K |
$1.91 | $100,101.75 | +30.33% | 225.62K |
Sep 24
| |||||||
Cidara Therapeutics, Inc.
| 10K |
—
|
—
| +3.67% | 282.32K |
Sep 12
| |||||||
Ideaya Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Cidara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 21
| |||||||
Cidara Therapeutics, Inc.
| -10.67K |
—
|
—
| -5.35% | 188.83K |
Feb 26
| |||||||
Paratek Pharmaceuticals, Inc.
| 7.5K |
—
|
—
| +74.07% | 17.63K |
Feb 26
| |||||||
Paratek Pharmaceuticals, Inc.
| -3.38K |
$7.14 | -$24,097.50 | -25.00% | 10.13K |
Feb 15
|
Scheduled
| ||||||
Cidara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 31
| |||||||
Cidara Therapeutics, Inc.
| -4.62K |
—
|
—
| -2.26% | 199.5K |
Nov 29
| |||||||
Cidara Therapeutics, Inc.
| 212.77K |
$4.70 | $1,000,000.20 | +382.99% | 268.32K |
May 23
| |||||||
Cidara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 29
| |||||||
Paratek Pharmaceuticals, Inc.
| 7.5K |
—
|
—
| +125.00% | 13.5K |
Feb 14
| |||||||
Cidara Therapeutics, Inc.
| 7.35K |
$6.79 | $49,906.50 | +16.52% | 51.85K |
Sep 12
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.